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Volume 59, Number 2 Abstracts 559patients, multivariate analysis showed HYBRID was associated with
signiﬁcantly higher rates of deep venous thrombosis/stroke (odds ratio,
13.6 vs 0.9; P ¼ .02) and prolonged intubation (odds ratio, 16.0 vs 1.8; P
¼ .003).
Conclusions: COPD patients should not be automatically excluded
from open TAR because the HYBRID procedure may not represent a safer
alternative.
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Objectives: Unsuitable endovascular anatomy presents a dilemma in
patients at high risk for open aortic aneurysm repair. We reviewed our expe-
rience with the off-label CHIMPS (CHIMney, Periscope, Snorkel)
approach to treat complex aortic aneurysms and deﬁne outcomes among
high-risk aortic aneurysm patients.
Methods: A retrospective analysis of all endovascular aortic proce-
dures performed between 2000 and 2013 was performed to identify patients
with CHIMPS endografts. CHIMPS patients were propensity-matched to
non-CHIMPS subjects by demographic and risk factors. Matched groups
were compared for outcomes. Signiﬁcance was statistically deﬁned using
c2 (or Fisher exact test), t-test, or Mann-Whitney U test. Kaplan-Meier
analysis was used to compare survival.
Results: The CHIMPS procedures were performed using 57 branch
stents in 38 patients (mean age, 71.9 6 13.8 years). CHIMPS were used
as initial endotherapy for 18 patients (47.3%). Indication for CHIMPS
included aneurysm diameter in 28 (mean 65 6 15 mm), rupture in 5, endo-
leak in 2, dissection in 1, dysphagia in 1, and mycotic aneurysm in 1.
Twenty-four procedures (63.1%) required stents in 1 vessel, 10 procedures
(26.3%) required 2 vessels, 3 procedures (7.8%) 3 vessels, and 1 procedure
(2.6%) required 4 vessels. Intraoperative endoleak was observed in 18 pa-
tients (47.3%): 12 with type I, 1 with type II, and 5 with type III. At 30
days, seven of these resolved and one additional type II endoleak was
observed. Of 57 total CHIMPS stents, four failed#30 days (three hypogas-
tric and one celiac). Two additional hypogastric CHIMPS stents failed
before the 12-month follow-up. No CHIMPS renal stents failed (n ¼
14). Thirty-day mortality was 10.5% (4 of 38) in nonemergency cases and
18.4% (7 of 38) with emergency cases, compared with 1.8% (2 of 114)
among matched EVAR patients. Among CHIMPS patients, two with
mesenteric stents and intentional exclusion of renals initiated hemodialysis.
Thirty-day glomerular ﬁltration rate estimates before and after procedures
did not differ signiﬁcantly between the groups. Kaplan-Meier analysis shows
decreased early survival but similar survival after 3 years in the matched
cohort.
Conclusions: The CHIMPS technique offers an alternative therapy in
patients with complex aneurysmal disease judged to be medically unsuitable
for open repair. Despite CHIMPS feasibility, these patients experience
increased mortality compared with a propensity-matched cohort.
Fig. Kaplan-Meier survival curves for patients treated using
CHIMPS technique and controls.Gastrointestinal Complications Following Fenestrated Endovascular
Aneurysm Repair
Martyn Knowles, MD, Jean J. Bao, MD, David A. Nation, MD, David E.
Timaran, MD, Luis F. Gomez, MD, M. Shadman Baig, MD, R. James
Valentine, MD, Carlos H. Timaran, MD. UT Southwestern, Dallas, Tex
Objectives: Fenestrated endovascular aneurysm repair (FEVAR) has
become an alternative in patients unﬁt for open repair and with morphology
not suitable to traditional endovascular aneurysm repair (EVAR). FEVAR
requires cannulation and stent placement within visceral vessels that could
lead to complications not seen after traditional EVAR, and little is known
about the gastrointestinal complications (GICs). This study was performed
to determine the prevalence of GICs after FEVAR.
Methods: Over a 5-year period, we prospectively gathered data on
148 patients who underwent FEVAR at our institution.
Results: The median number of vessels fenestrated was three (inter-
quartile range [IQR], 2-4), with a total of 457 vessels. Minor and major
GICs occurred in 59 patients (39.9%). There were 2 (1.4%) gastrointestinal
bleeds, 2 patients (1.4%) who developed cholecystitis, 1 patient (0.7%) who
developed liver failure, and 2 patients (1.4%) who developed Clostridium
difﬁcile infections. No patients developed pancreatitis, ascites, or small
bowel obstructions. Seventy patients (47.3%) had a history of abdominal
complaints, and 24 (34.3%) of these developed a GIC. Seventy-two patients
(48.6%) had a history of abdominal surgery, and 24 (33.3%) of these devel-
oped a GIC. An ileus developed in 55 patients (37.2%), with 11 (7.4%)
requiring a nasogastric tube and three (2.0%) requiring total parenteral
nutrition. Five patients (3.4%) were taken to the operating room for pre-
sumed colonic ischemia, which was conﬁrmed in two patients (1.4%), and
one patient (0.7%) was found to have gangrenous cholecystitis. No patients
developed small bowel ischemia. The median time to tolerate a diet in the
GIC group was 5 days (IQR, 3-6 days). The median intensive care unit
stay was signiﬁcantly higher in the GIC group than in those without com-
plications (5 [IQR, 3-9] vs 2 [IQR, 1-3] days, respectively; P < .0001).
When comparing patients who had a complication based on extent of
visceral stenting, there was a higher rate in those who underwent stenting
of the celiac artery compared with those that only included the renal arteries
(13 of 40 vs 27 of 56; P ¼ .003) and a higher complication rate comparing
above and below the SMA (13 of 40 [32.5%] vs 46 of 108 [42.6%]; P ¼
.002). Fourteen patients (9.5%) required readmission #30 days, nine
(6.1%) for a GIC, although none required surgical intervention.
Conclusions: Serious GICs after FEVAR are rare. However, ileus and
delayed return of bowel function are common and a major cause of
extended hospital stay. Not surprisingly, the level of complexity of FEVAR
appears to inﬂuence GIC rates.
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Objectives: This study measured changes in aortic diameter and vol-
ume after aneurysm repair using a multibranched thoracoabdominal stent
graft.
Method: Between September 2005 and May 2013, 120 patients un-
derwent aneurysm repair using multibranched thoracoabdominal stent
grafts. Follow-up included routine computed tomography (CT) at 1, 6,
and 12 months and yearly thereafter. We retrospectively compared the
initial postoperative CT angiography (CTA) with subsequent CTA using
three-dimensional analysis to measure changes in the maximum diameter
of the aneurysm and the volume of aorta encompassed by the stent graft.
Results: In 91 patients the CTA was adequate for serial measurement
of aneurysm diameter. Mean follow-up was 23.05 6 17.37 months.
Comparing the ﬁrst CTA with the most recent CTA, 52 patients
(57.14%) had >5-mm diameter decrease, 39 (42.86%) had <5-mm change,
and none had >5-mm increase. The CTA in 47 patients was adequate for
serial measurement of aortic volume. Of these, 35 (74.47%) had >5%
decreased in aortic volume, nine (19.15%) had <5% change, and three
(6.38%) had >5% increase. In the same group of 47 patients, diameter
decreased in 32 (68%) and remained stable in 15 (32%). This small differ-
ence in the frequency of aneurysm size change (up or down) between vol-
ume-based and diameter-based measurements was not signiﬁcant. The
correlation between volume change and diameter change was signiﬁcant
(P ¼ .006) but weak (R2 ¼ 0.16). Twenty-six patients (28.5%) had 30
endoleaks (type I, 6; type II, 19; type III, 5). The prevalence of diameter
decrease was slightly lower in patients with endoleaks than patients without.
The effect of endoleak on diameter might have been more signiﬁcant had
direct endoleaks (types I and III) not been treated. In three cases, endoleak
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initial aneurysm dilatation was followed by shrinkage. The failed treatment
of a type I endoleak in a case of aortoiliac dissection resulted in the only
rupture in the entire series. Type II endoleaks were not treated.
Conclusions: Persistent aneurysm dilatation was a rare event after
endovascular repair using a multibranched endovascular stent graft, prob-
ably because most direct endoleaks (types I and III) were treated, whereas
untreated type II endoleaks appear to have had little effect on aneurysm size.
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Objectives: Dialysis patients with peripheral vascular disease (PVD)
are at high risk for complications after surgical bypass, and it is not clear if
endovascular interventions have affected survival and limb salvage in this pa-
tient population. We sought to characterize the outcomes of endovascular
(endo) and open revascularization in dialysis patients treated for claudica-
tion or critical limb ischemia (CLI).
Methods: The United States Renal Data System (USRDS) was used
to review all patients undergoing lower extremity revascularization (LER)
in dialysis patients in the United States between 2005 and 2008. Diagnoses
and procedures were identiﬁed by International Classiﬁcation of Diseases-
9th Revision and Current Procedural Terminology codes, respectively. Pri-
mary outcomes were mortality and limb salvage. Bivariate associations were
tested using the c2 test, and predictors were identiﬁed using Cox regression
models.
Results: A total of 12,029 incident dialysis patients underwent LER
(24% endo, 76% open). CLI was the indication in 79.9% of endo LER,
and 72.8% of open LER. The major amputation rate #30 days for CLI pa-
tients was 15.1% (15.7% endo, 13.1% open; P ¼ .002) and for claudicant
patients was 5.2% (5.2% endo, 4.9% open; P ¼ .771). At 1 year, 32.0% of
CLI patients (33.0% endo, 29.1% open; P < .001) and 14.4% of claudicant
patients (14.0% endo, 16.4% open; P ¼ .254) had undergone a major ampu-
tation. The mortality rate at 30 days for CLI patients was 7.8% (7.2% endo,
9.8% open; P ¼ .001) and for claudicant patients was 5.2% (4.7% endo, 7.9%
open; P ¼ .018). At 1 year, the mortality rate was 38.4% for CLI patients
(37.6% endo, 40.9% open; P ¼ .005) and 25.7% for claudicant patients
(25.7% endo, 25.2% open; P ¼ .820). There were no signiﬁcant differences
between estimated survival for endo and open procedures at 1 year when
stratiﬁed by clinical indication. Estimated limb salvage differed signiﬁcantly
between open and endo LER only among CLI patients, with open LER
associated with improved limb salvage (P ¼ .001; Fig). Signiﬁcant pre-
dictors of post-LER mortality were older age (P < .001) and congestive
heart failure (P < .001).
Conclusions: Mortality and amputation rates after LER for dialysis
patients are signiﬁcant, particularly for patients with CLI. Although open
LER is associated with improved limb salvage compared with endo LER,
mortality is greater at 30 days and 1 year. Given the high overall mortality
rates, the presence of dialysis-dependence questions the indication for LER,
especially for claudication.
Fig. Amputation survival rates by indication and type of
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Objectives: Long-term results comparing percutaneous transluminal
angioplasty 6 stent (PTA/S) and surgical bypass grafting (BPG) for critical
limb ischemia (CLI) in patients who have had no prior intervention
have not been extensively reported. We detail our results with 3-year
follow-up.
Methods: We reviewed all lower extremity revascularization proce-
dures at our institution from January 2005 to December 2010, where
927 patients presented for CLI and underwent a ﬁrst-time intervention.
Outcomes included complications, restenosis, symptom recurrence, reinter-
ventions, minor and major amputations, and mortality. Predictors for
reintervention and amputation were identiﬁed using a Cox regression
model.
Results: Of the 927 patients, 519 underwent BPG and 408 under-
went PTA/S. BPG were above the knee in 58% (40% vein) and below
the knee in 42% (100% vein). Mean age was 70.5 years (BPG) vs 72.4 years
(PTA/S; P ¼ .03), with more males undergoing BPG (64% vs 52%; P <
.01). Mean length of stay was 10 days for BPG vs 7.4 days for PTA/S (P
¼ .02), with 3-year reintervention rates signiﬁcantly lower in patients under-
going BPG (42% vs 54%; P < .01). There were no differences in perioper-
ative mortality (3% vs 2%; not signiﬁcant). Wound infection was 11% in BPG
patients; however, BPG showed improved freedom from restenosis of 78%
vs 67% at 3 years (odds ratio [OR], 1.6; 95% conﬁdence interval [CI], 1.2-
2.1). A Cox regression model of all patients showed that a reintervention
#3 years was predicted by PTA/S (OR, 1.6; 95% CI, 1.1-2.3; Fig) and a
history of smoking (OR, 1.3; 95% CI, 1.0-1.6). Major amputations were
predicted by gangrenous indications (OR, 1.9; 95% CI, 1.1-3.5) and were
not predicted by procedure type.
Conclusions: BPG for the primary treatment of CLI showed
improved freedom from restenosis and signiﬁcantly fewer reinterventions
than PTA/S #3 years but was associated with increased length of stay
and wound infection. Perioperative mortality and 3-year amputation rates
were similar between procedure types.
Fig. Freedom from reintervention.
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Objectives: Acute lower extremity ischemia secondary to thrombo-
embolism is a common problem treated by vascular surgeons. Contem-
porary data regarding this problem are sparse. This report examines a
10-year single-center experience with acute lower extremity thrombo-
embolism and describes the surgical management and outcomes
observed.
